Guidance Notes and Best Practice Guides

NICE: Final draft guidance published recently by NICE, confirms its previous positive draft recommendation for naftidrofuryl oxalate as an option to treat people who suffer from intermittent claudication caused by peripheral arterial disease and for whom vasodilator therapy is considered appropriate after taking into account other treatment options.
Press release & links
Tame the Content Sprawl: Discover, Organise and Manage Enterprise Information from One Place